SANOFI.NS Earnings Date: Oct 30, 2026 (Estimated) — Sanofi India Limited

NSE

Updated Oct 30, 2026

Price —

Market Cap $73.8B

P/E 20.3

52W Range — – —

Next Earnings Oct 30, 2026 (est.)

When is SANOFI.NS's next earnings date?

Sanofi India Limited (SANOFI.NS) is expected to report earnings on Friday, October 30, 2026; the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of $44.15 on revenue of $4.76B.

How did SANOFI.NS do in its last earnings report?

In its most recent report on Aug 4, 2026, Sanofi India Limited posted EPS of $36.30 versus the $39.59 estimate, a miss. Revenue was $4.41B against a $4.43B estimate.

How much does SANOFI.NS stock move after earnings?

SANOFI.NS beat EPS estimates in 0 of its last 1 reported quarter.

About Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singapore and internationally. The company provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, infections, epilepsy, anti-infectives, and central nervous system, as well as allergy, pain care, digestive, and nutritional health under the Lantus, Toujeo, Soliqua, Clexane, Amaryl, Cardace, Lasix, Lasilactone, Glimepiride, Cetapin, Targocid, Frisium, Targocio, Combiflam, DePura, Allegra, Baralgan, BUSCOGAST, Dulcoflex, Enterogermina, Novalgin, and Avil brands through independent distributors. It also exports its products to approximately 24 countries. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.

🤖 AI Earnings Analysis

SANOFI.NS trades at 20.3× earnings with a 17.8% profit margin; valuation looks moderate, but the supplied data contains no recent news or earnings surprises.

AI-generated summary — powered by BigEarnings.